Integra LifeSciences Balance Sheet
NASDAQ: IARTHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Integra LifeSciences financial position
At the end of fiscal 2025, Integra LifeSciences reported total assets of $3.60 billion, down 10.8% from a year earlier against total liabilities of $2.56 billion. Shareholders' equity stood at $1.04 billion, or 29.0% of assets. The company held $235.0 million in cash and equivalents against $726.6 million of debt, a net debt position of $491.5 million.
The current ratio (current assets divided by current liabilities) was 2.54, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.70.
Summary generated from market data by MetaCap's automated system. Methodology
Integra LifeSciences balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 235.05M | 246.38M | 276.40M | 456.66M | 513.45M | 470.17M | 198.91M | 138.84M | 174.94M | 102.06M |
| Short-Term Investments | 28.69M | 27.19M | 32.69M | 0 | — | — | — | — | — | 0 |
| Receivables | 278.85M | 272.37M | 259.33M | 263.46M | 231.83M | 225.53M | 275.30M | 265.74M | 251.80M | 148.19M |
| Inventory | 492.74M | 429.09M | 389.61M | 324.58M | 317.39M | 310.12M | 316.05M | 280.35M | 296.33M | 217.26M |
| Total Current Assets | 1.16B | 1.08B | 1.06B | 1.16B | 1.15B | 1.24B | 858.17M | 775.08M | 822.15M | 495.17M |
| Property, Plant & Equipment | 444.33M | 405.72M | 340.20M | 311.30M | 311.70M | 287.53M | 337.40M | 300.11M | 269.25M | 222.37M |
| Goodwill | 615.16M | 1.10B | 1.06B | 1.04B | 1.01B | 932.37M | 954.28M | 926.48M | 937.90M | 510.57M |
| Intangible Assets | 1.13B | 1.21B | 1.07B | 1.13B | 1.15B | 989.44M | 1.03B | 1.08B | 1.16B | 561.17M |
| Total Assets | 3.60B | 4.04B | 3.78B | 3.89B | 3.78B | 3.62B | 3.30B | 3.11B | 3.21B | 1.81B |
| Accounts Payable | 95.73M | 82.50M | 92.33M | 102.10M | 61.84M | 54.61M | 113.09M | 76.05M | 93.97M | 29.06M |
| Total Current Liabilities | 455.98M | 922.13M | 306.98M | 320.91M | 340.02M | 401.01M | 331.31M | 262.55M | 348.91M | 123.60M |
| Long-Term Debt | 726.56M | 760.47M | 775.00M | 775.00M | 843.75M | 877.50M | 877.50M | 900.00M | — | — |
| Total Liabilities | 2.56B | 2.49B | 2.19B | 2.09B | 2.10B | 2.10B | 1.89B | 1.73B | 2.25B | 968.29M |
| Shareholders' Equity | 1.04B | 1.55B | 1.59B | 1.80B | 1.68B | 1.51B | 1.42B | 1.38B | 962.31M | 839.67M |
| Retained Earnings | 423.44M | 939.91M | 946.86M | 879.12M | 698.57M | 532.26M | 398.57M | 348.37M | 285.19M | 220.44M |
| Total Debt | 726.56M | 760.47M | 775.00M | 775.00M | 843.75M | 877.50M | 877.50M | 900.00M | — | — |
| Net Cash (Debt) | -462.82M | -486.90M | -465.90M | -318.34M | -330.30M | -407.33M | -678.59M | -761.16M | 174.94M | 102.06M |
This table shows 10 annual periods of Integra LifeSciences's balance sheet, from FY 2025 back to FY 2016, across 17 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow IART's reporting calendar. What is a balance sheet?